Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

NCT02299973 - Fecal Microbiota Transplantation (FMT) (own stool) vs Fecal Microbiota Transplantation (FMT) (healthy donor stool) & Diarrhea-predominant Irritable Bowel Syndrome (IBS) (IBS-D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Background:

Irritable bowel syndrome (IBS) is a gut disorder linked to intestinal dysbiosis. Open-label fecal microbiota transplantation (FMT) therapy has shown promise in patients with abdominal bloating (1).

Study overview:

NCT02299973 - Fecal Microbiota Transplantation (FMT) (own stool) vs Fecal Microbiota Transplantation (FMT) (healthy donor stool) & Irritable Bowel Syndrome (IBS) is a randomized, double-blind treatment trial studying Fecal Microbiota Transplantation (FMT) (own stool) vs Fecal Microbiota Transplantation (FMT) (healthy donor stool) in patients with [Diarrhea-predominant Irritable Bowel Syndrome (IBS) (IBS-D)](brain://0Gyo9mqTSUSufIJBAi…

References (Sources)

Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial
Holvoet et al. 2021 Gastroenterology 160(1): 145-157

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!